Our mission is to support our patients with mental or neurological disorders from the initial diagnostic to the end of the intervention, offering them state of the art technology to evaluate and treat ...

Tryptamine Therapeutics ( (AU:ENP)) just unveiled an update. Entropy Neurodynamics Limited has notified the market of the issue of 2 million unquoted options, each exercisable at A$0.08 and expiring ...

Entropy Neurodynamics Limited, a clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat ...

Dr. Adil Dalal, DBA - CEO, keynote speaker, leadership and AI pioneer. Author of 4 books and 10 global awards, inspiring leaders worldwide. The explosive growth of artificial intelligence (AI) is ...

Trailing total returns as of 12/23/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) Return TYPTF S&P/ASX 200 [XJO] (^AXJO) ...

What is the share price movement for Entropy Neurodynamics Limited (ENP)? Relative to the previous close share price of $0.04, Entropy Neurodynamics Limited's (ENP) current share price of $0.03 ...

Second infusion administered following clearance from Drug and Safety Monitoring Board after safety review of first infusion Patient will now undergo supportive psychotherapy, ahead of post-treatment ...